Does inhibition of aromatase by the specific inhibitor letrozole radiosensitize human breast cancer cells in vitro?

被引：0
|
作者：
Schmid-Bielenberg, D. [1 ]
Ohneseit, P. A. [1 ]
Krebiehl, G. [1 ]
Rodemann, H. P. [1 ]
机构：
[1] Sekt Strahlenbiol & Mol Umweltforsch, Tubingen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2006年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [21] Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients
    Trunet, PF
    Bhatnagar, AS
    Chaudri, HA
    Hornberger, U
    [J]. ACTA ONCOLOGICA, 1996, 35 (05) : 15 - 18
  • [22] Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer
    Lipton, Allan
    Leitzel, Kim
    Chaudri-Ross, Hilary A.
    Evans, Dean B.
    Ali, Suhail M.
    Demers, Laurence
    Hamer, Peter
    Brown-Shimer, Sheryl
    Pierce, Karen
    Gaur, Victor
    Carney, Walter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2653 - 2658
  • [23] Aromatase Inhibitor Letrozole in Synergy With Curcumin in the Inhibition of Xenografted Endometrial Carcinoma Growth
    Liang, Yuan-Jiao
    Hao, Qun
    Wu, Yuan-Zhe
    Wang, Qiao-Lian
    Wang, Jian-Dong
    Hu, Ya-Li
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (07) : 1248 - 1252
  • [24] Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole
    Bundred, Nigel J.
    Campbell, Ian D.
    Davidson, Neville
    DeBoer, Richard H.
    Eidtmann, Holger
    Monnier, Alain
    Neven, Patrick
    von Minckwitz, Gunter
    Miller, Joel C.
    Schenk, Nora L.
    Coleman, Robert E.
    [J]. CANCER, 2008, 112 (05) : 1001 - 1010
  • [25] ANTITUMOR EFFECT OF AROMATASE INHIBITOR, CGS16949A, ON HUMAN BREAST-CANCER CELLS
    YANO, S
    TANAKA, M
    NAKAO, K
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 289 (02): : 217 - 222
  • [26] Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole
    Karve, Aniruddha S.
    Desai, Janki M.
    Dave, Nimita
    Wise-Draper, Trisha M.
    Gudelsky, Gary A.
    Phoenix, Timothy N.
    DasGupta, Biplab
    Sengupta, Soma
    Plas, David R.
    Desai, Pankaj B.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (04) : 345 - 356
  • [27] Inhibition of drug metabolizing cytochrome P450s (CYPs) by the aromatase inhibitor drug letrozole in vitro.
    Jeong, S.
    Ward, B. A.
    Flockhart, D. A.
    Desta, Z.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S74 - S74
  • [28] Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole
    deJong, PC
    vandeVen, J
    Nortier, JWR
    MaitimuSmeele, I
    Donker, GH
    Thijssen, JHH
    Slee, PHTJ
    Blankenstein, MA
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 19 - 19
  • [29] Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole
    Aniruddha S. Karve
    Janki M. Desai
    Nimita Dave
    Trisha M. Wise-Draper
    Gary A. Gudelsky
    Timothy N. Phoenix
    Biplab DasGupta
    Soma Sengupta
    David R. Plas
    Pankaj B. Desai
    [J]. Cancer Chemotherapy and Pharmacology, 2022, 90 : 345 - 356
  • [30] Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third generation aromatase inhibitor vorozole
    de Jong, PC
    van de Ven, J
    Nortier, JWR
    Maitimu-Smeele, I
    Donker, GH
    Thijssen, JHH
    Slee, PHTJ
    Blankenstein, MA
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S5 - S5
12345